Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
biotech CEO
Pharma
Argenx isn't sweating over Vyvgart competitors: exec
Despite some recent competition from UCB, argenx is confident that it’s “just at the beginning of the growth curve” for Vyvgart in myasthenia gravis.
Fraiser Kansteiner
May 9, 2024 4:56pm
Biogen's fortunes are trending upward thanks to its new launches
Apr 24, 2024 11:24am
FibroGen, Kind Pharma settle trade secrets theft dispute
Apr 19, 2024 12:53pm
Genentech's Alexander Hardy steps down, will become BioMarin CEO
Nov 1, 2023 7:21pm
Vir taps Bayer dealmaker De Backer as its next CEO
Jan 25, 2023 11:20am
Scynexis to out license sole commercial med and cut sales team
Oct 20, 2022 3:45pm